1.
Explore the Factors Influencing Long-term Disease-free Survival of Childhood Acute Lymphoblastic Leukemia;
影响儿童急性淋巴细胞性白血病长期无病生存的因素探讨
2.
They cannot live for long periods in cold weather.
这种蝴蝶无法在寒冷天气中长期生存。
3.
FACTORS INFLUENCING LONG TERM SURVIVAL OF CHILDREN DISEASE TREATED BY RADIOTHERAPY
影响儿童何杰金氏病放射治疗长期生存的因素
4.
Analysis of Prognostic Factors on Long-term Survival of Acute Promyelocytic Leukemia
急性早幼粒细胞白血病长期生存预后因素分析
5.
Association of diabetes mellitus and treatment outcomes in patients with nasopharyngeal cancer
合并糖尿病对鼻咽癌患者长期生存率的影响
6.
Analysis of Factors on Long-term Survival in 217 Cases of Acute Promyelocytic Leukemia
急性早幼粒细胞白血病217例长期生存因素分析
7.
Her siege of illness left her languid and pallid.
疾病的长期折磨把她弄得倦怠不堪, 毫无生气。
8.
1988 Adjuvant chemotherapy proven to increase disease-free survival in early breast cancer.
1988年,证实应用辅助化疗治疗早期乳腺癌可以提高无病生存.
9.
Influences of Long-term of Different Dialysis Frequencies Per Week to the Patients with Maintenance Hemodialysis;
不同透析频率对维持性血液透析病人生存质量的中长期影响
10.
The impact of diabetes on long-term survival rate and complication in uremic patients during hemodialysis
糖尿病对血液透析患者长期生存率及并发症的影响
11.
Long-Term Survival Analysis in 89 Adult Patients with Acute Myeloid leukemia of Fusion Gene Aml1/Eto Positive
89例成人融合基因Aml1/Eto阳性急性髓系白血病长期生存分析
12.
Effect of high-dose cytarabine chemotherapy on long-term survival of patients with acute myeloid leukemia
大剂量阿糖胞苷强化疗对急性髓性白血病长期生存的影响
13.
The Clinical Characteristics and Prognostic Factors of Long-term Survived Patients with Recurrent and Metastatic Breast Cancer
长期生存复发转移性乳腺癌患者的临床病理特征和预后因素分析
14.
Research into Prolonging the Lifetime of Wireless Sensor Network Based on Clustering Algorithm;
基于分簇的无线传感器网络生存期延长策略研究
15.
Research on Prolonging the Lifetime of Wireless Sensor Network Based on Grid Algorithm;
基于网格的无线传感器网络生存期延长策略研究
16.
He was emaciated by long illness.
他由于长期生病而瘦弱。
17.
Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection
术后辅助化疗时间对Ⅲ期和高危Ⅱ期结直肠癌3年无病生存期的影响
18.
The 3-year overall survival (OS) and disease free survival ( DFS) was 66. 3% and 59. 5% , respectively.
3年总生存率和无病生存率分别为66．3％和59．5％。